N-Acetyl Semax Amidate Reference
Educational, not medical advice reference for N-Acetyl Semax Amidate: Cognitive, Nootropic; regulatory status, evidence posture, source review,…
Plain English
- What it is
- N-Acetyl Semax Amidate is a lab-made peptide sold as a research chemical, not an approved medicine. It is a tweaked version of an experimental brain peptide called Semax, with two small chemical changes added to it.
- What people use it for
- In the peptide community, people try it for focus, mental drive, and clearing brain fog. Many believe it feels stronger than regular Semax.
- What the science shows
- There are no dedicated human studies on this exact tweaked peptide. Almost all of the evidence comes from the parent peptide Semax, mostly in animals, plus chemistry work on the changes themselves. So the popular claims rest on extrapolation and personal reports, not direct proof.
- The catch
- This is not just Semax with better marketing. There is no official drug registry entry and no dedicated human evidence for this exact modified compound. The studies people point to are about the parent peptide Semax, not this changed version, and one lab study even found that adding the acetyl change removed a protective effect that plain Semax had. That means the tweaks are not proven to make it safer or work better.
Reference summary
Direct human evidence for N-acetyl Semax amidate is not established. Evidence is mostly parent Semax literature, chemistry / acetylation work, and compound-registry identity.
Regulatory and posture
- Categories
- Cognitive, Nootropic
- Aliases
- NA-Semax-Amidate, NAS, NASA, Ac-Semax-NH2
- Evidence posture
- preclinical - Modified parent-peptide extrapolation. Community focus and stimulant-like claims are not backed by independent human trials of this exact compound.
- Regulatory status
- No FDA-approved N-acetyl Semax amidate drug label. It is a modified Semax research chemical; parent Semax literature does not validate the modified compound as an approved nootropic.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubChem: N-acetyl Semax amidate compound record
- PubMed: N-terminal acetylation of Semax chemistry / biology study
- PubMed: Semax rat ischemia study
- PubMed: Semax neurotrophin rat study
For research and educational purposes only. Not medical advice.